Tenderwize
Retour à la recherche

Accord de remise pour Ganirelix

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Jun 27, 2028 · 584 days left·Open·Supplies·Framework
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Ganirelix (ATC-Code: H01CC01).

61/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

61 / 100

Complexité

65 / 100

Facteurs de risque

No contract value, minimum volume, guaranteed demand, or remuneration level is provided. The framework-style arrangemen...

The agreements may end automatically when exclusive rebate contracts enter into force, potentially before 31 August 202...

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Niedersachsen. Die Gesundheitskasse.
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Jun 27, 2028

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2028
  • Conclusion of non-exclusive rebate agreements for medicinal products containing Ganirelix, ATC code H01CC01.
  • Open-house model allowing eligible pharmaceutical companies to join during the contract period without a selection decision.
Afficher le résumé complet

Open-house, non-exclusive rebate agreement for medicinal products containing Ganirelix (ATC H01CC01) with AOK Niedersachsen, covering Germany from 1 September 2026 to 31 August 2028. Eligible pharmaceutical companies may join without a competitive selection decision under uniform, non-negotiable conditions. The agreement may end early if exclusive rebate contracts enter into force. Contract documents must be requested from AOK Niedersachsen; they were not provided for analysis.

Risques

No contract value, minimum volume, guaranteed demand, or remuneration level is provided. The framework-style arrangemen...

The agreements may end automatically when exclusive rebate contracts enter into force, potentially before 31 August 202...

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Participation is limited to pharmaceutical entrepreneurs within the meaning of Section 4(18) AMG, or a consortium of pharmaceutical entrepreneurs, in relation to the offered...
  • The pharmaceutical entrepreneur must have its seat in Germany, another EU Member State, or another EEA contracting state, as stated under Section 9(2) sentence 1 AMG.
  • Local representatives may participate only if they themselves qualify as pharmaceutical entrepreneurs for the relevant medicinal products.

Les exigences peuvent être incomplètes.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Ganirelix non-exclusive rebate agreement

Non-exclusive open-house rebate agreement under Section 130a(8) SGB V for medicinal products containing Ganirelix (ATC H01CC01). Contracts may be concluded with all eligible pharmaceutical companies under identical conditions. The lot data indicates a maximum duration of 24 months, with contracts ending no later than 31 August 2028.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

Aug 2026 - Aug 2028

Catégorie

Pharmaceutical products

Date limite

Deadline Jun 27, 2028

Détails de la procédure

Date de publication
05 Jul 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
464687-2026

Appels d'offres similaires

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy